DS7300-188 vVARY
Medable Inc.Download Options
Screenshots
About this app
You are invited to participate in the Daiichi Sankyo - DS7300-188 study.
A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.
Version Information
- Version
- -
- Downloads
- 10+
- Updated on
- -
- Released
- Apr 22, 2024
- Requires
- Android Varies with device
More from Medable Inc.
See more appsMedable
Free
TROPION-Lung07
Free
J1I-MC-GZQD
Free
J3M-MC-JZQB
Free
W8M-MC-LAA2
Free
GSK 219685
Free
NN7769-4532 Participant
Free
ZEUS Study App (EX6018-4758)
Free
W8M-MC-GN01
Free
GSK BEconneCTD-ILD Patient
Free
Avanti
Free
GSK 221458
Free
GSK BLISSc-ILD 218224 Patient
Free
THRIVE - Study Participant
Free
J4F-MC-CYAB
Free
BILUS Diary
Free